Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The Netherlands

Burak Kahn, Esther N. Pijnappel, Michel van Gelder, Otto Vissee, Arjan A. van de Loosdrecht, Gert J. Ossenkoppele, Jan J. Cornelissen, Avinash G. Dinmohamed, Mojca Jongen-Lavrencic

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)90-96
Number of pages7
JournalCancer Epidemiology
Volume57
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • Acute myeloid leukemia
  • Clinical trials
  • Comorbidity
  • Prognostication
  • Epidemiology
  • Therapy
  • RECEIVING INDUCTION CHEMOTHERAPY
  • CELL TRANSPLANTATION
  • OLDER PATIENTS
  • COMORBIDITY INDEX
  • SURVIVAL
  • ADULTS
  • MALIGNANCIES
  • THERAPY
  • CANCER
  • AGE

Cite this

Kahn, B., Pijnappel, E. N., van Gelder, M., Vissee, O., van de Loosdrecht, A. A., Ossenkoppele, G. J., Cornelissen, J. J., Dinmohamed, A. G., & Jongen-Lavrencic, M. (2018). Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The Netherlands. Cancer Epidemiology, 57, 90-96. https://doi.org/10.1016/j.canep.2018.09.007